CLOSEOUT LETTER
Service First Pharmacies Inc, dba Madison Drugs MARCS-CMS 492312 —
- Recipient:
- Service First Pharmacies Inc, dba Madison Drugs
United States
- Issuing Office:
United States
|
|
Office of Pharmaceutical Quality Operations, Division II |
|
|
August 14, 2017
Mr. Terry A. Wingo, Owner
Service First Pharmacies, Inc., dba Madison Drugs
8 Parade Street NW, Suite 100
Huntsville, Alabama 35806-4847
Dear Mr. Wingo:
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter (ref: WL# 2016-NOL-03) dated April 27, 2016. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
You are expected to take all necessary steps to assure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
LCDR John W. Diehl
Acting Director, Compliance Branch
Office of Pharmaceutical Quality Operations Division II
cc: Alabama State Board of Pharmacy
111 Village Street
Hoover, Alabama 35242